{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:59:59Z","timestamp":1793069999207,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T00:00:00Z","timestamp":1282176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1136\/ard.2010.130476","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T20:40:19Z","timestamp":1282250419000},"page":"2074-2082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":640,"title":["EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs"],"prefix":"10.1016","volume":"69","author":[{"given":"G K","family":"Bertsias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P A","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Aringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bollen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bombardieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I N","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dalakas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J G","family":"Hanly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T W J","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Isenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Scolding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Stara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Tassiulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tektonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tincani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"van Buchem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"van Vollenhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D T","family":"Boumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2010.130476_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR Standing Committee for International Clinical Studies including therapeutics","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X","article-title":"Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation","volume":"45","author":"Ainiala","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib4","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3899\/jrheum.081133","article-title":"Prospective study of neuropsychiatric events in systemic lupus erythematosus","volume":"36","author":"Hanly","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.130476_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.2007.077594","article-title":"Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)","volume":"67","author":"Andrade","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib6","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/rheumatology\/keh384","article-title":"Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort","volume":"43","author":"Mikdashi","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.130476_bib7","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/art.23098","article-title":"General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus","volume":"57","author":"Tomietto","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib8","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","article-title":"Epileptic seizures in systemic lupus erythematosus","volume":"63","author":"Appenzeller","year":"2004","journal-title":"Neurology"},{"key":"10.1136\/ard.2010.130476_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.62.9.859","article-title":"Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients","volume":"62","author":"Buj\u00e1n","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib10","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/01.WNL.0000165959.98370.D5","article-title":"Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus","volume":"64","author":"Mikdashi","year":"2005","journal-title":"Neurology"},{"key":"10.1136\/ard.2010.130476_bib11","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.130476_bib12","first-page":"622","article-title":"Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus","volume":"32","author":"Mok","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.130476_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(199801)41:1<41::AID-ART6>3.0.CO;2-7","article-title":"Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease","volume":"41","author":"Kozora","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2169\/internalmedicine.38.785","article-title":"Asymptomatic cerebrovascular lesions detected by magnetic resonance imaging in patients with systemic lupus erythematosus lacking a history of neuropsychiatric events","volume":"38","author":"Nomura","year":"1999","journal-title":"Intern Med"},{"key":"10.1136\/ard.2010.130476_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1136\/ard.48.12.1014","article-title":"Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus","volume":"48","author":"Sibbitt","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib16","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/brain\/awh646","article-title":"Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study","volume":"128","author":"Appenzeller","year":"2005","journal-title":"Brain"},{"key":"10.1136\/ard.2010.130476_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/ard.60.2.106","article-title":"Sensitivity of quantitative (1) H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus","volume":"60","author":"Axford","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib18","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/art.20512","article-title":"Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus","volume":"50","author":"Bosma","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib19","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/art.20654","article-title":"Selective gray matter damage in neuropsychiatric lupus","volume":"50","author":"Steens","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/02841850601105825","article-title":"Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigenvalues in different regions of the brain","volume":"48","author":"Hughes","year":"2007","journal-title":"Acta Radiol"},{"key":"10.1136\/ard.2010.130476_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/rheumatology\/kem354","article-title":"Single photon emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement","volume":"47","author":"Castellino","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.130476_bib22","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.21591","article-title":"Diagnostic value of single-photon-emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: a case-control study","volume":"53","author":"Zhang","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.59.5.377","article-title":"Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET","volume":"59","author":"Weiner","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/0961203303lu251oa","article-title":"Neuropsychiatric lupus favourable response to low dose i.v. cyclophosphamide and prednisolone (pilot study)","volume":"12","author":"Stojanovich","year":"2003","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.130476_bib25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2004.025528","article-title":"Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus","volume":"64","author":"Barile-Fabris","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1526-0968.2003.00032.x","article-title":"The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus","volume":"7","author":"Neuwelt","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1136\/ard.2010.130476_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/0961203307081840","article-title":"Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients","volume":"16","author":"Bartolucci","year":"2007","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.130476_bib28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1191\/096120399678841007","article-title":"A study of 20 SLE patients with intravenous immunoglobulin \u2013 clinical and serologic response","volume":"8","author":"Levy","year":"1999","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.130476_bib29","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s10067-004-1046-9","article-title":"Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature","volume":"24","author":"Milstone","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2010.130476_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semarthrit.2005.08.008","article-title":"Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome","volume":"35","author":"Vina","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2010.130476_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0049-0172(99)80029-8","article-title":"Clinical study and follow-up of 100 patients with the antiphospholipid syndrome","volume":"29","author":"Mu\u00f1oz-Rodriguez","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/qjmed\/93.8.523","article-title":"Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome","volume":"93","author":"Tektonidou","year":"2000","journal-title":"Q J Med"},{"key":"10.1136\/ard.2010.130476_bib35","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.23109","article-title":"A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies","volume":"57","author":"Ruiz-Irastorza","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature","volume":"76","author":"Cervera","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.2010.130476_bib37","first-page":"280","article-title":"Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies","volume":"31","author":"D'Cruz","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.130476_bib38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/0961203307081846","article-title":"Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus","volume":"16","author":"Heinlein","year":"2007","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.130476_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/0961203306074767","article-title":"Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients","volume":"16","author":"Tarr","year":"2007","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.130476_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0961203307084724","article-title":"Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients","volume":"17","author":"Hereng","year":"2008","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.130476_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib42","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/art.22663","article-title":"Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals","volume":"56","author":"Erkan","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib43","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/brain\/awh146","article-title":"A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth","volume":"127","author":"Mitsikostas","year":"2004","journal-title":"Brain"},{"key":"10.1136\/ard.2010.130476_bib44","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2010.130476_bib45","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","article-title":"A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)","volume":"3","author":"Finazzi","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1136\/ard.2010.130476_bib46","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archinte.162.10.1164","article-title":"Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5","volume":"162","author":"Ruiz-Irastorza","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1136\/ard.2010.130476_bib47","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0002-9343(96)00060-5","article-title":"Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry","volume":"100","author":"Finazzi","year":"1996","journal-title":"Am J Med"},{"key":"10.1136\/ard.2010.130476_bib48","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203309106832","article-title":"The Euro-Phospholipid Project: epidemiology of the antiphospholipid syndrome in Europe","volume":"18","author":"Cervera","year":"2009","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.130476_bib49","doi-asserted-by":"crossref","first-page":"c2541","DOI":"10.1136\/bmj.c2541","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"340","author":"Cohen","year":"2010","journal-title":"BMJ"},{"key":"10.1136\/ard.2010.130476_bib50","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/art.23090","article-title":"Impact of memory impairment on employment status in persons with systemic lupus erythematosus","volume":"57","author":"Panopalis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib51","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/03009740510026643","article-title":"Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study","volume":"34","author":"Ainiala","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.2010.130476_bib52","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/art.22031","article-title":"Anti-N-methyl-d-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus","volume":"54","author":"Lapteva","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s004150170138","article-title":"Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow","volume":"248","author":"Waterloo","year":"2001","journal-title":"J Neurol"},{"key":"10.1136\/ard.2010.130476_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/01.WNL.0000149640.78684.EA","article-title":"Predictors of cognitive dysfunction in patients with systemic lupus erythematosus","volume":"64","author":"McLaurin","year":"2005","journal-title":"Neurology"},{"key":"10.1136\/ard.2010.130476_bib55","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.wnl.0000180938.69146.5e","article-title":"Results of intervention for lupus patients with self-perceived cognitive difficulties","volume":"65","author":"Harrison","year":"2005","journal-title":"Neurology"},{"key":"10.1136\/ard.2010.130476_bib56","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1136\/ard.2004.029926","article-title":"Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study","volume":"64","author":"Haupt","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib57","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/art.1780400825","article-title":"Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study","volume":"40","author":"Hanly","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib58","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/art.1780370907","article-title":"Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus","volume":"37","author":"Denburg","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib59","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/096120330101001103","article-title":"Headache and memory loss: rapid response to heparin in the antiphospholipid syndrome","volume":"10","author":"Hughes","year":"2001","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.130476_bib60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000121423","article-title":"Clinical description of seizures in patients with systemic lupus erythematosus","volume":"59","author":"Gonz\u00e1lez-Duarte","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1136\/ard.2010.130476_bib61","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/01.wnl.0000267320.48939.d0","article-title":"CNS lupus: a study of 41 patients","volume":"69","author":"Joseph","year":"2007","journal-title":"Neurology"},{"key":"10.1136\/ard.2010.130476_bib62","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3899\/jrheum.080268","article-title":"Antiphospholipid antibody-associated chorea","volume":"35","author":"Orzechowski","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2010.130476_bib63","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/jnnp.55.12.1157","article-title":"Neuropsychiatric systemic lupus erythematosus in elderly people: a case series","volume":"55","author":"Dennis","year":"1992","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1136\/ard.2010.130476_bib64","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00005792-199711000-00006","article-title":"Cytotoxic therapy in systemic lupus erythematosus. Experience from a single center","volume":"76","author":"Rahman","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.2010.130476_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1212\/WNL.61.1.104","article-title":"Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus","volume":"61","author":"Chau","year":"2003","journal-title":"Neurology"},{"key":"10.1136\/ard.2010.130476_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2008.12.002","article-title":"Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study","volume":"32","author":"Briani","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.2010.130476_bib67","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.23218","article-title":"Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study","volume":"58","author":"Hanly","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib68","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/art.21539","article-title":"Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis","volume":"54","author":"Karassa","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jnnp.58.3.307","article-title":"Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms","volume":"58","author":"Kodama","year":"1995","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1136\/ard.2010.130476_bib70","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/art.20533","article-title":"Effects of a stress-reduction program on psychological function, pain, and physical function of systemic lupus erythematosus patients: a randomized controlled trial","volume":"51","author":"Greco","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib71","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/ard.56.8.481","article-title":"Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide","volume":"56","author":"Martin-Suarez","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9343(03)00135-9","article-title":"Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study","volume":"115","author":"Mok","year":"2003","journal-title":"Am J Med"},{"key":"10.1136\/ard.2010.130476_bib73","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/rheumatology\/ken260","article-title":"Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease","volume":"47","author":"Pego-Reigosa","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2010.130476_bib74","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib75","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1136\/ard.2010.130476_bib76","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","article-title":"Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0961203307088005","article-title":"Prognostic factors of lupus myelopathy","volume":"17","author":"Lu","year":"2008","journal-title":"Lupus"},{"key":"10.1136\/ard.2010.130476_bib78","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/brain\/awl010","article-title":"Skin denervation and cutaneous vasculitis in systemic lupus erythematosus","volume":"129","author":"Tseng","year":"2006","journal-title":"Brain"},{"key":"10.1136\/ard.2010.130476_bib79","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1034\/j.1600-0404.2001.103006386.x","article-title":"Peripheral neuropathy in systemic lupus erythematosus \u2013 a longitudinal study","volume":"103","author":"Omdal","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"10.1136\/ard.2010.130476_bib80","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.23452","volume":"58","author":"Emmer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib81","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1136\/ard.2010.130476_bib82","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1084\/jem.20071285","article-title":"Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis","volume":"204","author":"Matus","year":"2007","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2010.130476_bib83","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2006.055772","article-title":"Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus","volume":"66","author":"Zhang","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2010.130476_bib84","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/art.22451","article-title":"Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus","volume":"56","author":"Fragoso-Loyo","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2010.130476_bib85","doi-asserted-by":"crossref","first-page":"R551","DOI":"10.1186\/ar1228","article-title":"Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement","volume":"6","author":"Trysberg","year":"2004","journal-title":"Arthritis Res Ther"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724147541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724147541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2010.130476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:03:27Z","timestamp":1779249807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724147541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":85,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0003496724147541"],"URL":"https:\/\/doi.org\/10.1136\/ard.2010.130476","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2010.130476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}